Patients with liver cirrhosis and hyperammonemia ( at or above the institutional reference value ) and hypozincemia ( 65 g/dL ) were enrolled in the outpatient units of the participating institutions and were randomly divided to receive placebo ( P group ) or zinc acetate preparation at a dose of 3 capsules/d for a total zinc content of 150 mg/d ( Z group ) by the envelope method .